- Question from AllanJeffry: Are there any clinical trials available at M.D. Anderson Cancer Center that would benefit an IBC patient who has received treatment as you've outlined yet now has evidence of recurrence in the chest and brain metastases? Now evidently a stage IV patient.
- Answers - Gabriel N. Hortobagyi, M.D., F.A.C.P. In general terms, most clinical trials unfortunately do not include patients with brain metastases, mostly because of safety concerns. So at this point, and without looking at my priority list, I can't think of a specific clinical trial for patients with inflammatory breast cancer and brain metastases. We might have a clinical trial of new drugs for patients with metastatic brain cancer and brain metastases, and whether a particular patient could be a candidate would require a more in-depth assessment for all the relevant information. The right person to call for this would be Dr. Stacy Moulder at 713-792-2817, or Dr. Massimo Cristofanilli at the same number.
- Thomas Buchholz If the patient has brain metastases and has yet to receive treatment for them, it might be best to have their oncologist assess their overall performance status and the safety of traveling to a different institution, or whether they should receive radiation treatment to the brain.
The Ask-the-Expert Online Conference called Inflammatory Breast Cancer featured Gabriel Hortobagyi, M.D., Thomas Buchholz, M.D., and moderator Jennifer Sabol, M.D. answering your questions about inflammatory breast cancer, a rare but aggressive form of breast cancer.
Editor's Note: This conference took place in October 2006.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.